Print E-mail
Volume 50, Number 4, August 2017

Safety and efficacy of anti-influenza drugs, intravenous peramivir against influenza virus infection in elderly patients with underlying disease 

Kazufumi Takamatsu, Satoshi Marumo, Motonari Fukui, Atsuko Hata


Corresponding author:

Atsuko Hata, Corresponding author. Department of Infectious Diseases, Department of Infection Control, Department of Pediatrics, Division of Infectious Diseases, Tazuke Kofukai Medical Research Institute Kitano Hospital, 2-4-20 Ohgimachi, Kita-ku, Osaka 530-8480, Japan. Fax: +81 6 6312 8867. 


Background and purpose: 

We retrospectively analyzed data of 38 elderly patients, each with an underlying disease, to evaluate peramivir safety and efficacy. Six patients (15.8%) experienced adverse events, all tolerated. Median time from administration until the return to normal temperatures was 31.5 h (95% CI: 22.4–40.6). Results confirm intravenous peramivir's usefulness. 


Key words:

Aging, Antiviral drugs, Geriatrics, Gerontology, High-risk patient, Neuraminidase inhibitor